Aileron Therapeutics is a biopharmaceutical company dedicated to developing and commercializing a novel class of stapled peptides for the treatment of cancer and other diseases. The company's innovative approach leverages its proprietary platform to design and optimize therapeutic peptides that can target specific disease pathways with precision and efficacy. Aileron Therapeutics is committed to advancing the field of peptide-based therapeutics and improving patient outcomes through its cutting-edge research and development efforts.

Refer new talent to Aileron Therapeutics